ALLIGATOR BIOSCIENCE AB

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 11114
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 9246
 
  
 
C07K PEPTIDES 9127
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 693
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0304,437 BISPECIFIC MOLECULES CAPABLE OF SPECIFICALLY BINDING TO BOTH CTLA-4 AND CD40Jun 25, 14Oct 26, 17[A61K, C07K]
2017/0240,642 Anti-CD40 Antibodies, Uses and MethodsMay 08, 17Aug 24, 17[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9834589 CD86 variants with improved affinity for CTLA-4Jun 25, 14Dec 05, 17[A61K, G01N, C07K]
9676862 Anti-CD40 antibodies and methods of treating cancerSep 05, 12Jun 13, 17[A61K, C07K]
9486520 Compositions comprising polyglutamic acid nanoparticles and CD40 agonistsApr 13, 11Nov 08, 16[A61K]
9163072 Mutants of interleukin-1 receptor antagonistJul 10, 12Oct 20, 15[A61K, C07K]
8685640 Medical methods and agents for use thereinNov 17, 10Apr 01, 14[C12Q, G01N]
8303945 Mutants of interleukin-1 receptor antagonistMay 01, 08Nov 06, 12[A61K, C07K]
8071289 Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide moleculesFeb 25, 08Dec 06, 11[C07H, C12Q, C12P]
7816085 Method for in vitro molecular evolution of protein functionJul 16, 09Oct 19, 10[C12Q, C07K]
7563578 Method for in vitro molecular evolution of protein functionSep 20, 07Jul 21, 09[C07H, C12Q, C12P]
7282334 Method for in vitro molecular evolution of protein functionJul 20, 05Oct 16, 07[C12Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0368,318 MUTANTS OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AND USES THEREOFAbandonedFeb 12, 15Dec 24, 15[C07K]
8552149 Polypeptides and use thereofExpiredNov 30, 09Oct 08, 13[A61K, A61P, C07K]
8173774 Polypeptides and use thereofExpiredApr 20, 07May 08, 12[A61K, C07K]
2012/0077,730 Method for in Vitro Molecular Evolution of Protein FunctionAbandonedMar 31, 10Mar 29, 12[A61K, C12P]
7662551 Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide moleculesExpiredNov 18, 02Feb 16, 10[C07H, C12Q, C12P, C12N]
2009/0203,572 Method for in Vitro Molecular Evolution of Protein FunctionAbandonedNov 17, 06Aug 13, 09[A61K, C12Q, C12P, C12N, A61P, C40B, C07K]
2008/0242,605 CHEMOTAXIS-INHIBITING PROTEIN OF STAPHYLOCOCCUS (CHIPS) AND ITS USEAbandonedMar 27, 07Oct 02, 08[A61K, A61P, C07K]
2008/0233,137 Compounds that Block the C5a Receptor and Their Use in TherapyAbandonedApr 15, 05Sep 25, 08[A61K, A61P, C07K]
7388078 Nucleic acids encoding polypeptides having chips activityExpiredMar 08, 06Jun 17, 08[C07K]
7081513 Nucleic acids encoding (poly) peptides having chips activityExpiredJan 08, 01Jul 25, 06[A61K]
6958213 Method for in vitro molecular evolution of protein functionExpiredDec 12, 00Oct 25, 05[C07H, C12Q, C12P]
2005/0143,307 Chemotaxis-inhibiting protein of staphyloccocus (CHIPS) and its useAbandonedFeb 22, 05Jun 30, 05[A61K, C07K]
2002/0086,292 Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide moleculesAbandonedDec 22, 00Jul 04, 02[C07H, C12Q, C12P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.